• Port-a-Patch

    Smallest patch clamp setup in the world
  • Port-a-Patch

    Easy to learn - ideal for teaching
  • Port-a-Patch

    Records from cells, organelles and bilayers
  • Port-a-Patch

    First planar patch clamp device on the market
  • Port-a-Patch

    Ideal for internal solution exchange applications

2015 - The backstage pass to study your favorite TRP channel

icon pap   Port-a-Patch and   icon pl   Patchliner and SyncroPatch 384PE (a predecessor model of SyncroPatch 384i) and   icon sp96   SyncroPatch 384PE poster, TRP Meeting 2015   logo pdf   (2.2 MB)


TRP channels exhibit a large variety of functional properties and play diverse cellular and physiological roles. Due to their presence in the plasma membrane of cells from various tissues and even organelles, new biophysical properties and mechanisms of regulation are constantly discovered by academic laboratories over the years. Also, because of their relevance linked to disease and pain, TRP channels are important targets in the pharmaceutical industry.  Extensive functional studies of ion channels are often compromised by technical limitations of the electrophysiological assay. Nanion’s Port-A-Patch, Patchliner and SyncroPatch 384PE are specifically designed to marry the required experimental flexibility with high-throughput and Giga-seal data quality.  
In order to demonstrate reliable pharmacology combined with high-throughput electrophysiology we show data of TRPA1 activated by the agonist Supercinnamaldehyde and blocked by A-967079 in a concentration-dependent manner across a SyncroPatch 384 chip in a single experiment. With the aim to highlight experimental flexibility we present data using the internal perfusion of the SyncroPatch 384PE applying NMM (biotinylated NMethyl Maleimide) and AITC (allyl-iso-thiocyanat) to the intracellular side of the channel.  Intracellular organelles have been accessed using the Port-a-Patch in a report from Chen et al. (Nature Comm., 2014). Here, they measured whole lysosomes and demonstrated how synthetic small-molecule activators can restore mutant TRPML1 channel function to rescue disease associated abnormalities in mucolipidosis type IV. Furthermore, single channel traces of TRPA1 reconstituted into liposomes were recorded at various cold temperatures and the open probability was analysed. Finally, we show data featuring the temperature control of the Patchliner (available for the SyncroPatch 384PE shortly) by exposing TRPV1 and -V3 to a range of well defined temperatures and generating the corresponding activation curves.

Back to Overview

Cookies make it easier for us to provide you with our services. With the usage of our services you permit us to use cookies.
More information Ok